Skip to main content
Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.807
-0.074 (-8.34%)
At close: Nov 20, 2024, 4:00 PM
0.810
+0.003 (0.32%)
Pre-market: Nov 21, 2024, 4:02 AM EST

Lexicon Pharmaceuticals Revenue

Lexicon Pharmaceuticals had revenue of $1.75M in the quarter ending September 30, 2024, with 980.25% growth. This brings the company's revenue in the last twelve months to $5.23M, up 886.60% year-over-year. In the year 2023, Lexicon Pharmaceuticals had annual revenue of $1.20M with 766.19% growth.

Revenue (ttm)
$5.23M
Revenue Growth
+886.60%
P/S Ratio
44.92
Revenue / Employee
$18,347
Employees
285
Market Cap
291.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.20M1.07M766.19%
Dec 31, 2022139.00K-159.00K-53.36%
Dec 31, 2021298.00K-23.70M-98.76%
Dec 31, 202024.00M-298.08M-92.55%
Dec 31, 2019322.07M258.86M409.54%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cerus 176.23M
Spok Holdings 137.71M
Sanara MedTech 78.06M
AC Immune 48.51M
CVRx, Inc. 47.26M
Delcath Systems 22.64M
Absci 4.21M
Revenue Rankings

LXRX News

More News